Low-Dose Naltrexone: Unlocking the Therapeutic Potential
Naltrexone has advanced considerably since its primary use case decades ago to manage alcohol and opioid use disorder.
In this webinar for pharmacists and providers, we will present key clinical evidence of the therapeutic potential of low-dose naltrexone (LDN) for disease states ranging from chronic pain to inflammatory, autoimmune, dermatological, and more.
With the demand from patients for more therapeutic options higher than ever, LDN presents unique opportunities for healthcare professionals.
Learn how pharmacists can improve patient outcomes from compounded LDN.
Learn how providers can equip themselves with the necessary information about LDN so that patients can make informed decisions about their health.
Pharmacists and Physicians
- Recognize the factors contributing to a rise in demand for LDN.
- Identify the key characteristics distinguishing LDN from naltrexone, from dose to mechanism of action and clinical application.
- Describe the efficacy and safety of LDN based on clinical data across disease states such as chronic pain, inflammation, autoimmune diseases, and dermatological conditions.
- List the key elements of LDN (dosing, dosage forms, efficacy, safety, and more) to facilitate an effective decision-making process for patients.
|Single-core 1Ghz or higher
|Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent)
This webinar is Copyright © 2023 LP3 Network
|Michelle Moser, RPh, FAPC, FACA, FACVP, LDN Master Specialist
Michelle Moser is a leading expert LDN pharmacist with the mission to foster education and enhance awareness about the latest research on low-dose naltrexone to patients, pharmacists, and healthcare providers.
Michelle has more than 30 years’ pharmacy experience, focusing on personalized medicine so that patients meet their individual needs on their wellness journey. With her passion to improve health of patients with chronic illnesses, Michelle is involved with many research groups and support communities for LDN patients, providers, researchers, and pharmacists to facilitate and improve clarity on oftentimes, complex LDN information.
CANCELLATION AND REFUND POLICY
In the event that LP3 Network cancels a course, LP3 Network's sole liability shall be course repayment. In no event shall LP3 Network be responsible for any costs related to travel and/or accommodation. A written request must be sent to LP3 Network Inc. requesting ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. There are no refunds, returns, or transfer requests upon purchase of a home study, digital work book, webinar, and eLearning modules. LP3 NETWORK INC. shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to LP3 NETWORK INC. in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, LP3 NETWORK INC. will not issue any refunds, only transfer to an alternate live activity event date.